Cardio-Oncology Multidisciplinary Practice (COMP) 2023

Overview
This activity is for cardiology and oncology nurses, advanced practice registered nurses, pharmacists, and allied health care personnel who are involved in the management of patients with cancer and cardiovascular disease. Cardiovascular disease and cancer are the number one and two causes of death respectively in the United States. Both cardiology and oncology are rapidly evolving fields that often do not intersect in terms of their educational and training programs. With the development of new targeted cancer therapeutics all with unique cardiovascular toxicities, health care providers must be knowledgeable of both. There is not a consensus on how to diagnose, monitor, or even treat cardiovascular side effects of cancer and cancer therapeutics. This activity is designed to update health care providers on the new cancer therapeutics and a practical approach to diagnosing and treating the cardiovascular adverse events. The expected outcome will be that healthcare providers working in hospitals and in the community will be able to recognize and manage cardiovascular disease in cancer patients more effectively.

ANCC Learning Outcomes
At the conclusion of this activity, learners will be able to:

Articulate role in interprofessional collaboration to lead clinical, research and administrative innovation in cardio-oncology.
Explain the major differences from hospital- based and community-based Cardio-oncology programs.
Articulate the most common used anti-cancer agents associated with cardiotoxicities.